Cost-effectiveness analysis of cervical cancer screening strategies based on the papanicolaou smear test in Korea

Min Jung Ko, Jimin Kim, Younhee Kim, Yoon Jae Lee, Sung Ran Hong, Jae Kwan Lee

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Despite the increasing number of screening examinations performed for cervical cancer utilizing the Papanicolaou smear test (Pap test), few studies have examined whether this strategy is cost-effective in Korea. Objective: This study was conducted to evaluate the cost-effectiveness of cervical cancer screening strategies incorporating the Pap test based on age at the start and end of screening as well as screening interval. Materials and Methods: We designed four alternative screening strategies based on patient age when screening was started (20 or 30 years) and discontinued (lifetime, 79 years). Each strategy was assessed at screening intervals of 1, 2, 3, or 5 years. A Markov model was developed to determine the cost-effectiveness of the 16 possible cervical cancer screening strategies, and this was evaluated from a societal perspective. The main outcome measures were average lifetime cost, incremental quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratio (ICER). Results: Compared with various strategies comprising younger starting age, discontinuation age, and longer screening intervals, strategies employing annual screening for cervical cancer starting at a target age of 30 years and above were the most cost-effective, with an ICER of 21,012.98 dollars per QALY gained (with a Korean threshold of 30,000,000 KRW or US$27,272). Conclusions: We found that annual screening for cervical cancer beginning at a target age of 30 years and above is most cost-effective screening strategy. Considering the potential economic advantages, more intense screening policies for cervical cancer might be favorable among countries with high rates of cervical cancer and relatively low screening costs.

Original languageEnglish
Pages (from-to)2317-2322
Number of pages6
JournalAsian Pacific Journal of Cancer Prevention
Volume16
Issue number6
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Papanicolaou Test
Korea
Early Detection of Cancer
Uterine Cervical Neoplasms
Cost-Benefit Analysis
Costs and Cost Analysis
Quality-Adjusted Life Years
Economics
Outcome Assessment (Health Care)

Keywords

  • Cancer screening
  • Cervical cancer
  • Economic evaluation
  • HPV infection
  • Pap smear test

ASJC Scopus subject areas

  • Epidemiology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Cancer Research

Cite this

Cost-effectiveness analysis of cervical cancer screening strategies based on the papanicolaou smear test in Korea. / Ko, Min Jung; Kim, Jimin; Kim, Younhee; Lee, Yoon Jae; Hong, Sung Ran; Lee, Jae Kwan.

In: Asian Pacific Journal of Cancer Prevention, Vol. 16, No. 6, 01.01.2015, p. 2317-2322.

Research output: Contribution to journalArticle

Ko, Min Jung ; Kim, Jimin ; Kim, Younhee ; Lee, Yoon Jae ; Hong, Sung Ran ; Lee, Jae Kwan. / Cost-effectiveness analysis of cervical cancer screening strategies based on the papanicolaou smear test in Korea. In: Asian Pacific Journal of Cancer Prevention. 2015 ; Vol. 16, No. 6. pp. 2317-2322.
@article{117cb1af7cb4403d9d0eaad95312761a,
title = "Cost-effectiveness analysis of cervical cancer screening strategies based on the papanicolaou smear test in Korea",
abstract = "Background: Despite the increasing number of screening examinations performed for cervical cancer utilizing the Papanicolaou smear test (Pap test), few studies have examined whether this strategy is cost-effective in Korea. Objective: This study was conducted to evaluate the cost-effectiveness of cervical cancer screening strategies incorporating the Pap test based on age at the start and end of screening as well as screening interval. Materials and Methods: We designed four alternative screening strategies based on patient age when screening was started (20 or 30 years) and discontinued (lifetime, 79 years). Each strategy was assessed at screening intervals of 1, 2, 3, or 5 years. A Markov model was developed to determine the cost-effectiveness of the 16 possible cervical cancer screening strategies, and this was evaluated from a societal perspective. The main outcome measures were average lifetime cost, incremental quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratio (ICER). Results: Compared with various strategies comprising younger starting age, discontinuation age, and longer screening intervals, strategies employing annual screening for cervical cancer starting at a target age of 30 years and above were the most cost-effective, with an ICER of 21,012.98 dollars per QALY gained (with a Korean threshold of 30,000,000 KRW or US$27,272). Conclusions: We found that annual screening for cervical cancer beginning at a target age of 30 years and above is most cost-effective screening strategy. Considering the potential economic advantages, more intense screening policies for cervical cancer might be favorable among countries with high rates of cervical cancer and relatively low screening costs.",
keywords = "Cancer screening, Cervical cancer, Economic evaluation, HPV infection, Pap smear test",
author = "Ko, {Min Jung} and Jimin Kim and Younhee Kim and Lee, {Yoon Jae} and Hong, {Sung Ran} and Lee, {Jae Kwan}",
year = "2015",
month = "1",
day = "1",
doi = "10.7314/APJCP.2015.16.6.2317",
language = "English",
volume = "16",
pages = "2317--2322",
journal = "Asian Pacific Journal of Cancer Prevention",
issn = "1513-7368",
publisher = "Asian Pacific Organization for Cancer Prevention",
number = "6",

}

TY - JOUR

T1 - Cost-effectiveness analysis of cervical cancer screening strategies based on the papanicolaou smear test in Korea

AU - Ko, Min Jung

AU - Kim, Jimin

AU - Kim, Younhee

AU - Lee, Yoon Jae

AU - Hong, Sung Ran

AU - Lee, Jae Kwan

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background: Despite the increasing number of screening examinations performed for cervical cancer utilizing the Papanicolaou smear test (Pap test), few studies have examined whether this strategy is cost-effective in Korea. Objective: This study was conducted to evaluate the cost-effectiveness of cervical cancer screening strategies incorporating the Pap test based on age at the start and end of screening as well as screening interval. Materials and Methods: We designed four alternative screening strategies based on patient age when screening was started (20 or 30 years) and discontinued (lifetime, 79 years). Each strategy was assessed at screening intervals of 1, 2, 3, or 5 years. A Markov model was developed to determine the cost-effectiveness of the 16 possible cervical cancer screening strategies, and this was evaluated from a societal perspective. The main outcome measures were average lifetime cost, incremental quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratio (ICER). Results: Compared with various strategies comprising younger starting age, discontinuation age, and longer screening intervals, strategies employing annual screening for cervical cancer starting at a target age of 30 years and above were the most cost-effective, with an ICER of 21,012.98 dollars per QALY gained (with a Korean threshold of 30,000,000 KRW or US$27,272). Conclusions: We found that annual screening for cervical cancer beginning at a target age of 30 years and above is most cost-effective screening strategy. Considering the potential economic advantages, more intense screening policies for cervical cancer might be favorable among countries with high rates of cervical cancer and relatively low screening costs.

AB - Background: Despite the increasing number of screening examinations performed for cervical cancer utilizing the Papanicolaou smear test (Pap test), few studies have examined whether this strategy is cost-effective in Korea. Objective: This study was conducted to evaluate the cost-effectiveness of cervical cancer screening strategies incorporating the Pap test based on age at the start and end of screening as well as screening interval. Materials and Methods: We designed four alternative screening strategies based on patient age when screening was started (20 or 30 years) and discontinued (lifetime, 79 years). Each strategy was assessed at screening intervals of 1, 2, 3, or 5 years. A Markov model was developed to determine the cost-effectiveness of the 16 possible cervical cancer screening strategies, and this was evaluated from a societal perspective. The main outcome measures were average lifetime cost, incremental quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratio (ICER). Results: Compared with various strategies comprising younger starting age, discontinuation age, and longer screening intervals, strategies employing annual screening for cervical cancer starting at a target age of 30 years and above were the most cost-effective, with an ICER of 21,012.98 dollars per QALY gained (with a Korean threshold of 30,000,000 KRW or US$27,272). Conclusions: We found that annual screening for cervical cancer beginning at a target age of 30 years and above is most cost-effective screening strategy. Considering the potential economic advantages, more intense screening policies for cervical cancer might be favorable among countries with high rates of cervical cancer and relatively low screening costs.

KW - Cancer screening

KW - Cervical cancer

KW - Economic evaluation

KW - HPV infection

KW - Pap smear test

UR - http://www.scopus.com/inward/record.url?scp=84929193408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929193408&partnerID=8YFLogxK

U2 - 10.7314/APJCP.2015.16.6.2317

DO - 10.7314/APJCP.2015.16.6.2317

M3 - Article

C2 - 25824757

AN - SCOPUS:84929193408

VL - 16

SP - 2317

EP - 2322

JO - Asian Pacific Journal of Cancer Prevention

JF - Asian Pacific Journal of Cancer Prevention

SN - 1513-7368

IS - 6

ER -